Last $32.54 USD
Change Today +1.11 / 3.53%
Volume 144.4K
LGND On Other Exchanges
Symbol
Exchange
NASDAQ GM
OTC BB
Frankfurt
OTC BB
OTC BB
OTC BB
As of 8:10 PM 06/18/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John L. Higgins

Chief Executive Officer, President and Executive Director, Ligand Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 30 board members in 3 different organizations across 5 different industries.

See Board Relationships
42$2,371,336
As of Fiscal Year 2012

Background*

Mr. John L. Higgins has been the Chief Executive Officer and President of Ligand Pharmaceuticals Inc. of Metabasis Therapeutics Inc. since January 16, 2007. Mr. Higgins serves as the President and Chief Executive Officer of Moonstone Acquisition, Inc. He has over 14 years of corporate development, financing, strategic planning, commercialization and investment banking experience in the Biopharmaceutical Industry. Prior to joining Ligand Pharmaceuticals Inc., he served ...

Read Full Background

Corporate Headquarters*

11119 North Torrey Pines Road
La Jolla, California 92037

United States

Phone: 858-550-7500
Fax: --

Board Members Memberships*

2004-2013
Former Director
2007-Present
Chief Executive Officer, President and Executive Director
2008-Present
Director
2009-Present
Director, Member of Audit Committee, Member of Executive Compensation Committee and Member of Nominations & Governance Committee

Education*

BA
Colgate University

Other Affiliations*

Annual Compensation*

Salary$484,517
Total Annual Compensation$484,517

Stock Options*

Restricted Stock Awards$86,820
All Other Compensation$2,715
Exercisable Options249,499
Unexercisable Options208,166
Total Number of Options457,665

Total Compensation*

Total Annual Cash Compensation$850,620
Total Short Term Compensation$484,517
Other Long Term Compensation$89,535
Total Calculated Compensation$2,371,336
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LGND:US $32.54 USD +1.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Frank C. Condella Jr.Chief Executive Officer, President and Director
Columbia Laboratories Inc.
$325.0K
Stephen M. Simes Vice Chairman, Chief Executive Officer and President
BioSante Pharmaceuticals, Inc.
$496.7K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGAND PHARMACEUTICALS-CL B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.